Header Logo

Ryan Nipp

Concepts (378)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms
68
2025
765
16.240
Why?
Palliative Care
26
2024
79
6.470
Why?
Pancreatic Neoplasms
19
2025
515
5.570
Why?
Quality of Life
33
2025
465
5.170
Why?
Patient Reported Outcome Measures
15
2025
58
4.780
Why?
Gastrointestinal Neoplasms
14
2023
34
4.610
Why?
Hospitalization
18
2023
189
4.330
Why?
Aged
86
2025
5212
3.760
Why?
Medical Oncology
8
2025
86
3.660
Why?
Lung Neoplasms
13
2022
339
3.570
Why?
Humans
146
2025
27067
3.210
Why?
Cost of Illness
12
2025
51
3.140
Why?
Adenocarcinoma
9
2025
285
3.120
Why?
Terminal Care
9
2022
43
2.670
Why?
Clinical Trials as Topic
6
2023
205
2.380
Why?
Male
83
2025
13003
2.350
Why?
Middle Aged
64
2025
6882
2.340
Why?
Depression
13
2021
212
2.160
Why?
Female
86
2025
14613
2.140
Why?
Aged, 80 and over
36
2025
1936
2.140
Why?
Carcinoma, Non-Small-Cell Lung
6
2022
102
2.100
Why?
Patient Acceptance of Health Care
6
2025
90
1.940
Why?
Patient Participation
7
2021
53
1.890
Why?
Antineoplastic Agents
9
2024
658
1.770
Why?
Caregivers
9
2025
111
1.630
Why?
Adaptation, Psychological
7
2018
117
1.580
Why?
Health Care Costs
5
2020
49
1.530
Why?
Antineoplastic Combined Chemotherapy Protocols
9
2023
375
1.510
Why?
Carcinoma, Pancreatic Ductal
6
2021
132
1.510
Why?
Sarcopenia
3
2021
42
1.450
Why?
Surveys and Questionnaires
19
2025
928
1.410
Why?
Adult
39
2025
7476
1.370
Why?
Patient Readmission
3
2022
103
1.360
Why?
Health Services Accessibility
5
2021
90
1.360
Why?
Patient Selection
4
2021
143
1.290
Why?
Prognosis
20
2021
763
1.280
Why?
Neoadjuvant Therapy
6
2024
69
1.250
Why?
Geriatrics
2
2021
41
1.230
Why?
Symptom Assessment
4
2022
15
1.160
Why?
Colorectal Neoplasms
6
2021
133
1.120
Why?
Cancer Survivors
4
2021
39
1.080
Why?
Carcinoma, Squamous Cell
3
2024
152
1.070
Why?
Esophageal Neoplasms
2
2024
31
1.030
Why?
Physician-Patient Relations
4
2020
112
1.020
Why?
Geriatric Assessment
4
2025
87
0.990
Why?
Camptothecin
2
2015
15
0.980
Why?
Cross-Sectional Studies
17
2025
919
0.970
Why?
Survivors
5
2021
36
0.930
Why?
Medicare Part D
1
2024
5
0.930
Why?
Prescription Drugs
1
2024
15
0.930
Why?
Lobbying
1
2024
9
0.910
Why?
Germ-Line Mutation
1
2024
29
0.910
Why?
Informed Consent
2
2021
23
0.890
Why?
Genetic Testing
1
2024
64
0.890
Why?
United States
15
2025
2056
0.860
Why?
Medicare
5
2020
119
0.850
Why?
Affect
4
2020
82
0.840
Why?
Inpatients
2
2022
56
0.830
Why?
SEER Program
7
2023
46
0.830
Why?
Treatment Outcome
7
2021
2278
0.790
Why?
Body Composition
3
2021
262
0.780
Why?
Length of Stay
6
2023
215
0.780
Why?
Personal Satisfaction
1
2022
27
0.770
Why?
Healthcare Disparities
3
2021
87
0.760
Why?
Insurance Coverage
5
2021
31
0.760
Why?
Severity of Illness Index
3
2019
445
0.760
Why?
Anxiety
9
2022
140
0.750
Why?
Telemedicine
3
2025
145
0.730
Why?
Hematology
1
2021
24
0.730
Why?
Head and Neck Neoplasms
1
2022
84
0.720
Why?
Health Expenditures
7
2025
29
0.710
Why?
Muscle, Skeletal
4
2021
622
0.710
Why?
Analgesics, Opioid
1
2022
104
0.710
Why?
Registries
3
2021
383
0.700
Why?
Hospice Care
5
2021
15
0.700
Why?
Electronics
1
2020
4
0.690
Why?
Activities of Daily Living
2
2019
100
0.680
Why?
Monitoring, Physiologic
1
2020
55
0.670
Why?
Income
2
2019
38
0.650
Why?
Financial Statements
1
2019
2
0.650
Why?
Financing, Personal
1
2019
4
0.650
Why?
Travel
1
2019
12
0.650
Why?
Monitoring, Ambulatory
1
2019
26
0.640
Why?
Early Detection of Cancer
1
2020
122
0.630
Why?
Pain Management
2
2025
56
0.620
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2023
40
0.620
Why?
Self Report
4
2022
116
0.620
Why?
Emergency Service, Hospital
1
2020
117
0.620
Why?
Patient Protection and Affordable Care Act
1
2018
10
0.610
Why?
Antidepressive Agents
1
2018
29
0.610
Why?
Leukemia, Myeloid, Acute
2
2022
32
0.610
Why?
Age Factors
7
2021
721
0.600
Why?
Breast Neoplasms
6
2020
447
0.590
Why?
Stress Disorders, Post-Traumatic
1
2018
68
0.570
Why?
Multimorbidity
1
2017
3
0.560
Why?
Communication
2
2019
170
0.560
Why?
Drug Industry
1
2016
12
0.550
Why?
Conflict of Interest
1
2016
15
0.550
Why?
Delivery of Health Care
4
2024
111
0.550
Why?
Pragmatic Clinical Trials as Topic
1
2016
5
0.540
Why?
Pancreatectomy
1
2017
56
0.540
Why?
Decision Making
5
2025
170
0.530
Why?
Prospective Studies
11
2023
1219
0.530
Why?
Young Adult
10
2023
2624
0.520
Why?
Retrospective Studies
17
2022
2450
0.510
Why?
Anxiety Disorders
1
2016
59
0.510
Why?
Carboxylesterase
1
2015
1
0.500
Why?
Patient Preference
4
2025
29
0.500
Why?
Fluorouracil
6
2022
53
0.490
Why?
Immunotherapy
5
2022
138
0.490
Why?
Pilot Projects
4
2024
396
0.490
Why?
Research Design
1
2016
174
0.480
Why?
Life Style
1
2015
83
0.480
Why?
Health Knowledge, Attitudes, Practice
1
2017
282
0.460
Why?
Leucovorin
5
2022
16
0.450
Why?
Randomized Controlled Trials as Topic
5
2022
364
0.440
Why?
Follow-Up Studies
8
2019
985
0.440
Why?
Hospitals, Special
1
2013
3
0.430
Why?
ADP-ribosyl Cyclase 1
1
2013
10
0.430
Why?
Chemoradiotherapy
3
2024
44
0.420
Why?
Chemokines
1
2013
73
0.420
Why?
Survival Rate
9
2020
408
0.410
Why?
Quality Assurance, Health Care
1
2013
62
0.410
Why?
Analgesics
1
2012
35
0.410
Why?
Veterans
1
2013
66
0.400
Why?
Aging
2
2019
951
0.390
Why?
Neoplasm Metastasis
6
2020
150
0.390
Why?
Lymphoma, Non-Hodgkin
2
2021
21
0.380
Why?
Neoplasm Staging
5
2019
462
0.370
Why?
Pain
2
2015
254
0.360
Why?
Cytokines
1
2013
439
0.360
Why?
Circulating Tumor DNA
2
2021
2
0.360
Why?
Antiemetics
2
2020
4
0.360
Why?
Psychometrics
4
2019
117
0.360
Why?
Insurance, Health
4
2021
51
0.360
Why?
Precision Medicine
2
2021
67
0.360
Why?
Socioeconomic Factors
4
2019
242
0.360
Why?
Massachusetts
3
2019
16
0.350
Why?
Stress, Psychological
4
2021
211
0.350
Why?
Ambulatory Care
2
2021
58
0.350
Why?
Goals
2
2020
33
0.340
Why?
Gastroenterologists
2
2019
6
0.330
Why?
End Stage Liver Disease
2
2019
9
0.320
Why?
Intensive Care Units
2
2019
46
0.320
Why?
Antineoplastic Agents, Immunological
2
2020
38
0.320
Why?
Patient Care Planning
2
2020
24
0.310
Why?
Kaplan-Meier Estimate
3
2018
189
0.310
Why?
Patient Discharge
2
2020
97
0.310
Why?
Health Care Surveys
2
2018
67
0.300
Why?
Neoplasm Recurrence, Local
3
2018
312
0.290
Why?
Adolescent
5
2023
2986
0.280
Why?
Patient Outcome Assessment
2
2019
14
0.280
Why?
Cachexia
2
2020
51
0.280
Why?
Combined Modality Therapy
2
2018
290
0.270
Why?
Oncologists
3
2021
15
0.270
Why?
Biomarkers, Tumor
3
2023
377
0.270
Why?
Family
2
2017
98
0.270
Why?
Liver Neoplasms
2
2020
164
0.260
Why?
Longitudinal Studies
4
2023
404
0.260
Why?
Cancer Pain
1
2025
11
0.240
Why?
Feasibility Studies
2
2025
191
0.240
Why?
Cost Savings
1
2024
19
0.230
Why?
Mass Screening
2
2024
141
0.230
Why?
Biomedical Research
1
2025
93
0.220
Why?
Nausea
2
2020
16
0.220
Why?
Vomiting
2
2020
13
0.220
Why?
Autoimmune Diseases
1
2025
162
0.210
Why?
Natural Language Processing
1
2023
16
0.210
Why?
Lymphoma, Large B-Cell, Diffuse
1
2023
26
0.200
Why?
Coronary Vasospasm
1
2022
4
0.200
Why?
Prescriptions
1
2022
2
0.200
Why?
Mutation
3
2021
818
0.200
Why?
Cancer Care Facilities
1
2021
7
0.190
Why?
Logistic Models
3
2020
398
0.190
Why?
Lymphoma, Follicular
1
2021
13
0.190
Why?
Rectal Neoplasms
1
2021
8
0.190
Why?
Patient Satisfaction
1
2022
89
0.190
Why?
Mental Health Services
1
2021
18
0.190
Why?
Neoplasm, Residual
1
2021
30
0.190
Why?
Videoconferencing
1
2021
10
0.180
Why?
Telephone
1
2021
25
0.180
Why?
Inflammatory Bowel Diseases
1
2021
39
0.180
Why?
Gastroenterology
1
2021
14
0.180
Why?
Research
1
2021
88
0.180
Why?
Genetic Predisposition to Disease
1
2024
655
0.180
Why?
Siblings
2
2018
23
0.180
Why?
Poverty
2
2024
82
0.180
Why?
Fellowships and Scholarships
1
2021
38
0.180
Why?
Tomography, X-Ray Computed
2
2021
466
0.180
Why?
Neoplasms, Second Primary
1
2020
21
0.180
Why?
Weight Loss
1
2021
72
0.180
Why?
Child
4
2021
2159
0.170
Why?
Fatigue
3
2020
63
0.170
Why?
Anus Neoplasms
1
2020
4
0.170
Why?
Practice Patterns, Physicians'
1
2022
160
0.170
Why?
Indians, North American
1
2024
514
0.170
Why?
Veterans Health
1
2019
6
0.170
Why?
Cell-Free Nucleic Acids
1
2019
3
0.170
Why?
Liquid Biopsy
1
2019
8
0.170
Why?
DNA, Neoplasm
1
2019
33
0.170
Why?
Losartan
1
2019
4
0.170
Why?
Nursing Homes
1
2019
43
0.160
Why?
Guideline Adherence
1
2020
91
0.160
Why?
Pandemics
1
2021
167
0.160
Why?
Public Health Surveillance
1
2019
5
0.160
Why?
Sexual Behavior
1
2020
87
0.160
Why?
High-Throughput Nucleotide Sequencing
1
2020
105
0.160
Why?
Carcinoma, Hepatocellular
1
2020
130
0.160
Why?
Advance Care Planning
1
2019
14
0.160
Why?
Carcinoma, Large Cell
1
2018
6
0.160
Why?
Quality of Health Care
2
2021
78
0.160
Why?
Atrial Fibrillation
1
2023
398
0.160
Why?
Attitude
1
2019
42
0.160
Why?
Decision Support Techniques
1
2018
49
0.160
Why?
Chemoradiotherapy, Adjuvant
1
2018
12
0.150
Why?
Prescription Fees
1
2018
3
0.150
Why?
Liver Transplantation
1
2019
51
0.150
Why?
Antibodies, Monoclonal, Humanized
2
2020
133
0.150
Why?
Psychological Tests
1
2018
21
0.150
Why?
Adipose Tissue
1
2020
180
0.150
Why?
Costs and Cost Analysis
1
2018
39
0.150
Why?
Delivery of Health Care, Integrated
1
2018
13
0.150
Why?
Program Evaluation
1
2019
162
0.150
Why?
Tumor Burden
1
2018
108
0.150
Why?
Health Services Needs and Demand
1
2018
36
0.150
Why?
Managed Care Programs
1
2018
16
0.150
Why?
Anorexia
2
2015
4
0.150
Why?
Qualitative Research
3
2025
173
0.150
Why?
Time-to-Treatment
1
2018
26
0.150
Why?
Employment
1
2018
45
0.150
Why?
Terminally Ill
1
2017
2
0.150
Why?
Blood Vessels
1
2018
58
0.150
Why?
Resuscitation Orders
1
2017
9
0.150
Why?
Attitude to Death
1
2017
13
0.150
Why?
Professional-Patient Relations
1
2017
28
0.140
Why?
Regression Analysis
1
2018
209
0.140
Why?
Pancreaticoduodenectomy
1
2017
42
0.140
Why?
Health Surveys
1
2017
77
0.140
Why?
Endocrine Gland Neoplasms
1
2017
2
0.140
Why?
Aromatase Inhibitors
1
2017
2
0.140
Why?
Postoperative Complications
1
2022
605
0.140
Why?
Financial Support
1
2016
9
0.140
Why?
Molecular Targeted Therapy
1
2018
126
0.140
Why?
Psychiatric Status Rating Scales
1
2017
93
0.140
Why?
Hospital Mortality
1
2017
146
0.140
Why?
Interpersonal Relations
1
2017
64
0.140
Why?
Guidelines as Topic
1
2016
44
0.140
Why?
Glioma
1
2018
117
0.140
Why?
Health Status
1
2017
145
0.130
Why?
Physicians
1
2016
80
0.130
Why?
Melanoma
1
2017
128
0.130
Why?
Forecasting
1
2016
71
0.130
Why?
Delphi Technique
1
2015
17
0.120
Why?
African Americans
1
2018
350
0.120
Why?
Evidence-Based Medicine
1
2016
141
0.120
Why?
Social Support
1
2016
123
0.120
Why?
Organoplatinum Compounds
1
2015
23
0.120
Why?
Emotions
1
2016
131
0.120
Why?
Sex Characteristics
1
2015
163
0.120
Why?
Bevacizumab
1
2015
93
0.120
Why?
Colonic Neoplasms
1
2016
116
0.120
Why?
Cohort Studies
3
2023
859
0.110
Why?
Prostatic Neoplasms
1
2017
270
0.110
Why?
Body Weight
1
2014
248
0.110
Why?
Frail Elderly
1
2013
15
0.110
Why?
Quality Indicators, Health Care
1
2013
49
0.110
Why?
Lymphatic Metastasis
3
2018
119
0.110
Why?
Consultants
1
2012
4
0.100
Why?
Data Collection
1
2013
101
0.100
Why?
Quality Improvement
1
2013
113
0.100
Why?
Gene Expression
1
2013
408
0.090
Why?
Time Factors
3
2020
1570
0.090
Why?
Cognition Disorders
1
2013
181
0.090
Why?
Glucose Intolerance
1
2011
22
0.090
Why?
Magnesium
1
2011
40
0.090
Why?
Comorbidity
2
2023
252
0.090
Why?
Proto-Oncogene Proteins B-raf
2
2021
29
0.090
Why?
Polycystic Ovary Syndrome
1
2011
64
0.090
Why?
Pain Measurement
2
2025
163
0.090
Why?
Postural Balance
1
2009
38
0.080
Why?
Hospices
2
2020
6
0.080
Why?
Insulin Resistance
1
2011
171
0.080
Why?
Survivorship
2
2021
11
0.080
Why?
Exercise Test
1
2009
248
0.080
Why?
Walking
1
2009
130
0.070
Why?
B7-H1 Antigen
2
2018
35
0.070
Why?
Programmed Cell Death 1 Receptor
2
2018
37
0.070
Why?
Hypertension
1
2011
305
0.070
Why?
Karnofsky Performance Status
2
2020
15
0.070
Why?
Incidence
2
2021
553
0.070
Why?
Neoplasm Invasiveness
2
2018
180
0.070
Why?
Survival Analysis
2
2020
278
0.070
Why?
Body Mass Index
2
2021
389
0.060
Why?
Charities
1
2025
1
0.060
Why?
Obesity
1
2011
654
0.060
Why?
Patient Care Team
1
2024
63
0.060
Why?
Child, Preschool
2
2018
1099
0.060
Why?
Carcinoembryonic Antigen
1
2023
3
0.060
Why?
Bendamustine Hydrochloride
1
2023
2
0.050
Why?
Rituximab
1
2023
60
0.050
Why?
Bone Marrow Transplantation
1
2023
42
0.050
Why?
Electronic Health Records
1
2023
60
0.050
Why?
Minority Groups
1
2023
64
0.050
Why?
Calcium Channel Blockers
1
2022
36
0.050
Why?
Nitrates
1
2022
46
0.050
Why?
Microsatellite Repeats
1
2021
55
0.050
Why?
Drug Costs
1
2021
17
0.050
Why?
Drugs, Generic
1
2021
6
0.050
Why?
Radiotherapy
1
2021
39
0.050
Why?
Pharmacies
1
2021
19
0.050
Why?
Biological Specimen Banks
1
2021
8
0.050
Why?
Hematologic Tests
1
2021
7
0.050
Why?
Immunologic Factors
1
2021
48
0.050
Why?
Oncology Service, Hospital
1
2020
1
0.050
Why?
New England
1
2020
8
0.050
Why?
alpha-Fetoproteins
1
2020
18
0.040
Why?
Hospital Costs
1
2020
29
0.040
Why?
Hospitals
1
2021
71
0.040
Why?
Transportation of Patients
1
2020
28
0.040
Why?
Sexual Dysfunction, Physiological
1
2020
6
0.040
Why?
Pneumonia, Aspiration
1
2019
4
0.040
Why?
Dehydration
1
2019
6
0.040
Why?
Renal Insufficiency
1
2019
20
0.040
Why?
Health Planning Guidelines
1
2019
6
0.040
Why?
Perception
1
2020
83
0.040
Why?
Whole Exome Sequencing
1
2019
9
0.040
Why?
Autopsy
1
2019
24
0.040
Why?
Radiation Injuries
1
2020
51
0.040
Why?
Genetic Heterogeneity
1
2019
30
0.040
Why?
Urinary Tract Infections
1
2019
39
0.040
Why?
Intersectoral Collaboration
1
2019
7
0.040
Why?
Waiting Lists
1
2019
9
0.040
Why?
Odds Ratio
1
2019
230
0.040
Why?
Databases, Factual
1
2020
251
0.040
Why?
Cultural Competency
1
2019
18
0.040
Why?
Pneumonia
1
2019
89
0.040
Why?
Sepsis
1
2019
81
0.040
Why?
Referral and Consultation
1
2019
87
0.040
Why?
Drug Resistance, Neoplasm
1
2019
148
0.040
Why?
Proportional Hazards Models
1
2018
217
0.040
Why?
Disease Progression
1
2020
457
0.040
Why?
Attitude of Health Personnel
1
2019
139
0.040
Why?
Antacids
1
2017
6
0.040
Why?
Enzyme Replacement Therapy
1
2017
4
0.040
Why?
Models, Statistical
1
2018
122
0.040
Why?
Pancreatic Diseases
1
2017
13
0.040
Why?
Cause of Death
1
2017
66
0.040
Why?
Cardiopulmonary Resuscitation
1
2017
27
0.040
Why?
Needs Assessment
1
2017
53
0.040
Why?
Tamoxifen
1
2017
31
0.030
Why?
Disease-Free Survival
1
2017
225
0.030
Why?
Family Health
1
2016
71
0.030
Why?
Linear Models
1
2016
201
0.030
Why?
Mental Health
1
2016
96
0.030
Why?
Antibodies, Monoclonal
1
2017
317
0.030
Why?
Risk Assessment
1
2017
595
0.030
Why?
Dyspnea
1
2015
25
0.030
Why?
Constipation
1
2015
21
0.030
Why?
Infant, Newborn
1
2018
846
0.030
Why?
Internationality
1
2014
31
0.030
Why?
Syndrome
1
2014
78
0.030
Why?
Infant
1
2018
964
0.030
Why?
Consensus
1
2014
69
0.030
Why?
Risk Factors
1
2020
2029
0.030
Why?
Terminology as Topic
1
2014
53
0.030
Why?
Prevalence
1
2015
478
0.030
Why?
Waist Circumference
1
2011
18
0.020
Why?
Body Weights and Measures
1
2009
18
0.020
Why?
Hand Strength
1
2009
36
0.020
Why?
Lipids
1
2011
198
0.020
Why?
Accidental Falls
1
2009
31
0.020
Why?
Blood Pressure
1
2011
351
0.020
Why?
Gait
1
2009
58
0.020
Why?
Blood Glucose
1
2011
306
0.020
Why?
Analysis of Variance
1
2009
388
0.020
Why?
Chronic Disease
1
2009
263
0.020
Why?
Heart Rate
1
2009
375
0.020
Why?
Biomarkers
1
2011
738
0.020
Why?
Nipp's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (378)
Explore
_
Co-Authors (32)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_